Trial intelligence / Profile preview

Oral sodium thiosulfate for calcium kidney stones

IRCT20231017059748N2Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in nephrolithiasis comparing Sodium thiosulfate plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoints: Change in kidney stone dimensions, Urine test parameters and 3 more. Started Nov 2023; status: completed.

02

Drugs

sodium thiosulfate
03

Conditions

nephrolithiasis

Beyond the preview

Go deeper on IRCT20231017059748N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20231017059748N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call